group B streptococcal infection vaccine (VaxNewMo)

N/A

Report date: 2025/12/18 17:46:28

Base Information

Drug Namegroup B streptococcal infection vaccine (VaxNewMo)
Drug Alias Namemultivalent polysaccharide conjugated vaccine (VaxNewMo)GBS bioconjugate vaccine (VaxNewMo)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsStreptococcus group B infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOmniose
China Registration ClassN/A

Develop Information

Active CompaniesOmniose
Inactive CompaniesN/A
Active IndicationsStreptococcus group B infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A